日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial)

自体肿瘤浸润淋巴细胞局部区域治疗葡萄膜黑色素瘤伴肝转移患者的 I 期试验(HAITILS 试验)

Nelson, Axel; Riise, Rebecca; Alsén, Samuel; Wong, Andrew; Carlson, Per; Edman, Sebastian; Holgersson, Jan; Olofsson Bagge, Roger; Johansson, Iva; Sadik, May; Edenbrandt, Lars; Nilsson, Lisa M; Nilsson, Jonas A; Ny, Lars

Involvement of KEAP1/NRF2 pathway in non-BRAF mutated squamous cell carcinoma of the thyroid.

KEAP1/NRF2通路参与非BRAF突变型甲状腺鳞状细胞癌的发生发展

Schoultz Elin, Dahlberg Jakob, Nilsson Lisa M, Dzanan Jozefina J, Carlsson Therese, Dahr Niklas, Andersson Ellinor, Muhammad Ghayeb, Muth Andreas, Elias Erik, Fagman Henrik, Sayin Volkan I, Nilsson Jonas A, Nilsson Mikael

Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy

转移性葡萄膜黑色素瘤患者的趋化因子分析表明,CCL21信号通路在表观遗传疗法和免疫检查点疗法的联合治疗中发挥作用。

Sah, Vasu R; Jespersen, Henrik; Karlsson, Joakim; Nilsson, Lisa M; Bergqvist, Mattias; Johansson, Iva; Carneiro, Ana; Helgadottir, Hildur; Levin, Max; Ullenhag, Gustav; Ståhlberg, Anders; Olofsson Bagge, Roger; Nilsson, Jonas A; Ny, Lars

A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells

一部分来自结直肠癌肝转移的CD8+ T细胞优先在自体患者来源的异种移植肿瘤中重新增殖,成为组织驻留记忆T细胞。

Liang, Frank; Nilsson, Lisa M; Byvald, Fabian; Rezapour, Azar; Taflin, Helena; Nilsson, Jonas A; Yrlid, Ulf

Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models

胰腺癌患者来源异种移植模型的遗传学和肿瘤浸润淋巴细胞治疗反应

Nilsson, Lisa M; Vilhav, Caroline; Karlsson, Joakim W; Fagman, Johan Bourghardt; Giglio, Daniel; Engström, Cecilia E; Naredi, Peter; Nilsson, Jonas A

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

PEMDAC 开展的帕博利珠单抗联合恩替诺特治疗转移性葡萄膜黑色素瘤患者的 II 期研究

Ny, Lars; Jespersen, Henrik; Karlsson, Joakim; Alsén, Samuel; Filges, Stefan; All-Eriksson, Charlotta; Andersson, Bengt; Carneiro, Ana; Helgadottir, Hildur; Levin, Max; Ljuslinder, Ingrid; Olofsson Bagge, Roger; Sah, Vasu R; Stierner, Ulrika; Ståhlberg, Anders; Ullenhag, Gustav; Nilsson, Lisa M; Nilsson, Jonas A

BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma

BET 溴结构域抑制剂 HMBA 与 MEK 抑制剂协同作用治疗恶性胶质瘤

Elisa Funck-Brentano, Dzeneta Vizlin-Hodzic, Jonas A Nilsson, Lisa M Nilsson

The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after Expansion

小肠神经内分泌肿瘤微环境含有扩增后可识别和激活的淋巴细胞

Tobias Hofving, Frank Liang, Joakim Karlsson, Ulf Yrlid, Jonas A Nilsson, Ola Nilsson, Lisa M Nilsson

Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

更正:一项患者来源的异种移植临床前试验揭示了转移性黑色素瘤对卡罗努迪布的治疗反应和耐药机制

Einarsdottir, Berglind O; Karlsson, Joakim; Söderberg, Elin M V; Lindberg, Mattias F; Funck-Brentano, Elisa; Jespersen, Henrik; Brynjolfsson, Siggeir F; Bagge, Roger Olofsson; Carstam, Louise; Scobie, Martin; Koolmeister, Tobias; Wallner, Olof; Stierner, Ulrika; Berglund, Ulrika Warpman; Ny, Lars; Nilsson, Lisa M; Larsson, Erik; Helleday, Thomas; Nilsson, Jonas A